Breaking News

OmniComm, RELICO in Strategic Pact

June 13, 2013

Will combine eClinical expertise

OmniComm Systems, Inc. and Reliable Lifesciences Consulting (RELICO) have entered a strategic partnership that will allow OmniComm to offer EDC project management and support through its own Europe-based support services, while allowing RELICO to offer study build and support services to its clients.
OmniComm's System Integrator Partner Program focuses on building out a global support of companies dedicated to the eClinical market place. According to OmniComm, its key products, TrialMaster and TrialOne, offer an intuitive user experience and lower total cost of ownership. RELICO offers expertise across different platforms, such as multivendor eClinical systems integration, with diverse functional requirements and capabilities.
"OmniComm is delighted to partner with RELICO," said Stephen Johnson, president and chief operating officer, OmniComm Systems. "RELICO's vast experience and good standing in the life science community, extends the reach for OmniComm particularly within Europe and the Middle East. They have a distinctive reputation for efficiency and scalability, managing projects for large pharma and small biotech alike and more importantly, getting it right the first time."
"By becoming an OmniComm partner, RELICO is aligning itself with the fastest growing EDC providers in the industry," said Dr. Hauke Kindler, RELICO's chief executive officer and founder. "Their proven reliability and very strong focus on interoperability and innovation is seeing them out-perform the older, aging EDC systems that are currently available."
  • Packaging Equipment Close-Up

    Packaging Equipment Close-Up

    Kristin Brooks, Contract Pharma||March 9, 2016
    To meet the wide-ranging needs of the marketplace, suppliers and contract packagers are looking to deliver flexible solutions.

  • Top 25 Pharma and Biopharma Report

    Top 25 Pharma and Biopharma Report

    July 20, 2015
    (Based on 2014 Sales, in $U.S. Millions)

  • Driving Innovation Through Contracting

    Driving Innovation Through Contracting

    David Agrella, Bryan Haas, Pharm.D., Timothy King, Dr.P.H. and Scott Maisto , PPD||November 13, 2014
    This article discusses the advantages to both biopharmaceutical companies and their vendors of moving outsourcing spend to a commercial model focused on the desired deliverable and not the level of effort required to achieve the deliverable.